You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 28, 2025

Bulgaria Drug Patents


✉ Email this page to a colleague

« Back to Dashboard


Drug Patents in Bulgaria and US Equivalents

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
Patent NumberEstimated ExpirationEquivalent US PatentUS Expiry DateGeneric NameUS ApplicantUS Tradename
103959 ⤷  Try for Free 6294540 2018-11-14 abacavir sulfate Viiv Hlthcare ZIAGEN
64390 ⤷  Try for Free 6294540 2018-11-14 abacavir sulfate Viiv Hlthcare ZIAGEN
60914 ⤷  Try for Free 5905082 2016-11-18 abacavir sulfate; lamivudine Viiv Hlthcare EPZICOM
98254 ⤷  Try for Free 5905082 2016-11-18 abacavir sulfate; lamivudine Viiv Hlthcare EPZICOM
60679 ⤷  Try for Free 6180639 2018-01-30 abacavir sulfate; lamivudine Viiv Hlthcare EPZICOM
103959 ⤷  Try for Free 6294540 2018-11-14 abacavir sulfate; lamivudine Viiv Hlthcare EPZICOM
64390 ⤷  Try for Free 6294540 2018-11-14 abacavir sulfate; lamivudine Viiv Hlthcare EPZICOM
>Patent Number>Estimated Expiration>Equivalent US Patent>US Expiry Date>Generic Name>US Applicant>US Tradename
Showing 1 to 7 of 7 entries

Patentability, Enforceability, and Scope of Claims for Biopharmaceutical Patents in Bulgaria

Legislative Basis for Intellectual Property Protection

In Bulgaria, the protection of intellectual property, including biopharmaceutical patents, is grounded in the Constitution and several specific laws. Articles 17 and 54 of the Constitution guarantee the protection of intellectual property rights, including patents, copyrights, and related rights[1].

Relevant Laws and Regulations

  • Patent Law: The Law on Patents and Utility Model Registration is the primary legislation governing patent applications in Bulgaria. This law aligns with EU legislation and international agreements such as TRIPS[1][4].
  • Biotechnological Inventions: The EU Directive 98/44/EC on the legal protection of biotechnological inventions is applicable in Bulgaria, ensuring harmonization with EU standards. Biotechnological inventions are patentable if they meet the criteria of novelty, inventiveness, and industrial applicability[3].

Patentability of Biopharmaceutical Inventions

Criteria for Patentability

To be patentable, biopharmaceutical inventions must fulfill the following criteria:

  • Novelty: The invention must be new and not publicly disclosed before the filing date.
  • Inventiveness: The invention must involve an inventive step, meaning it must be non-obvious to a person skilled in the field.
  • Industrial Applicability: The invention must be capable of industrial application[2][4].

Specific Considerations for Biotechnological Inventions

Biotechnological inventions, including those in the biopharmaceutical sector, are subject to the rules outlined in EU Directive 98/44/EC. This includes products consisting of or containing biological material and processes involving biological material. These inventions are patentable if they meet the general patentability requirements[3].

Application and Examination Process

Filing Requirements

  • A patent application must include a request for the grant of a patent, the title of the invention, and the data identifying the applicant, all in the Bulgarian language.
  • The application must contain a description of the invention, claims, drawings if necessary, and an abstract.
  • If documents are filed in a language other than Bulgarian, translations must be provided within three months to maintain the filing date[4][5].

Examination Stages

  • Formal Examination: The Bulgarian Patent Office checks for compliance with formal requirements. Deficiencies must be corrected within three months.
  • Preliminary Examination and Substantive Examination: The application is reviewed for novelty, inventiveness, and industrial applicability. This process typically takes around 13 months from the filing date[2][4].

Enforceability of Biopharmaceutical Patents

Civil Procedure

Civil claims can be filed before the civil court in Bulgaria for infringement of intellectual property rights. The court can award sanctions, including fines and damages, as specified in the relevant IP laws, which are harmonized with EU legislation and international acts[1].

Administrative Procedure

The Bulgarian Patent and Trademark Office (PTO) can investigate and detain counterfeit goods and issue fines against infringers upon application. However, these fines are nominal and most effective when the identity of the infringer is known[1].

Criminal Procedure

Criminal proceedings can be initiated against infringers under the Criminal Code. The police and the Criminal Court can confiscate counterfeit goods and prosecute the infringers upon request by the right holder or their legal representative[1].

Scope of Claims

Definition of Claims

The claims in a patent application must clearly define the matter for which legal protection is sought and must be supported by the description. Each claim must be expressed in a single sentence[4].

Protection Term

The maximum term of protection for a patent in Bulgaria is 20 years from the filing date. For pharmaceutical and plant protection products, this term can be extended up to 25 years with a Supplementary Protection Certificate (SPC)[4][5].

Maintenance and Fees

Annual Fees

To maintain the patent right, annual fees must be paid to the Bulgarian Patent Office. These fees can be paid in advance, and late payment is possible within a six-month grace period with a surcharge[5].

National Phase Entry for PCT Applications

For international patent applications under the Patent Cooperation Treaty (PCT), the national phase entry in Bulgaria must be made within 31 months from the priority date. The application must include a request for the grant of a patent, applicant's and inventor's details, and proof of payment of the corresponding fees. If the applicant is not established in Bulgaria or the EU, they must use a lawyer or industrial property representative[5].

Key Takeaways

  • Patentability Criteria: Biopharmaceutical inventions must meet the criteria of novelty, inventiveness, and industrial applicability.
  • Application Process: Applications must be filed in Bulgarian, with translations provided within three months if necessary.
  • Examination Process: Formal, preliminary, and substantive examinations are conducted by the Bulgarian Patent Office.
  • Enforceability: Civil, administrative, and criminal procedures are available for enforcing patent rights.
  • Scope of Claims: Claims must be clear and supported by the description, with a maximum protection term of 20 years (extendable to 25 years with SPC).
  • Maintenance: Annual fees must be paid to maintain the patent right.

FAQs

  1. What are the key criteria for patenting biopharmaceutical inventions in Bulgaria?

    • The key criteria include novelty, inventiveness, and industrial applicability, as outlined in the EU Directive 98/44/EC and Bulgarian Patent Law[3][4].
  2. How long does the patent examination process typically take in Bulgaria?

    • The patent examination process typically takes around 13 months from the filing date, with the entire process from filing to grant taking an average of 2-5 years[2][5].
  3. What is the maximum term of protection for a biopharmaceutical patent in Bulgaria?

    • The maximum term of protection is 20 years from the filing date, extendable to 25 years with a Supplementary Protection Certificate (SPC) for pharmaceutical and plant protection products[4][5].
  4. Can a patent application be filed in a language other than Bulgarian?

    • Yes, but translations into Bulgarian must be provided within three months to maintain the filing date[4][5].
  5. What are the enforcement options for biopharmaceutical patent rights in Bulgaria?

    • Enforcement options include civil claims, administrative proceedings, and criminal proceedings[1].

Sources

  1. PETOŠEVIĆ - Intellectual Property Protection in Bulgaria[1]
  2. Privacy Shield - Bulgaria - Protection Intellectual Property[2]
  3. European Commission - Patent protection in the EU[3]
  4. Innovaccess - Patent in Bulgaria[4]
  5. IP-Coster - PCT national phase entry in Bulgaria[5]

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.